[ad_1] Klaus Sindahl, head of IR at Hansa Biopharma, discusses how he took the firm’s IR strategy to the next level and won the trust of sell-side analysts When Klaus…
Tag: Hansa
Hansa Biopharma to host conference call to provide interim results for January-March 2023 and a Business Update
[ad_1] LUND, Sweden, April 14, 2023 /PRNewswire/ — Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-March 2023 at 8:00 CET on April 20, 2023. All interested…